⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SUPN News
Supernus Pharmaceuticals, Inc.
Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program
globenewswire.com
SUPN
Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
SUPN
Supernus Pharmaceuticals to Participate in September Investor Conferences
globenewswire.com
SUPN
SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
SUPN
Multiple System Atrophy Clinical Trial Pipeline Gains Momentum: 22+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
ASMB
IONS
BIIB
ALT
TEVA
ANVS
SUPN
ABBV
AVXL
MRK
KAR
VNDA
Global Neurodiagnostics Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight
globenewswire.com
ABBV
AMRN
AXSM
BMY
BIIB
BSX
LLY
GSK
JNJ
MDT
NVS
NVO
SNPS
SUPN
TMO
ABT
XOM
Global Neurodegenerative Disease Market is Expected to Showcase Significant Growth at a CAGR of ~6% by 2034 | DelveInsight
globenewswire.com
NVO
LLY
BMY
AXSM
JNJ
SNY
BIIB
ABBV
MRK
REGN
GILD
AMGN
AZN
TEVA
BHC
ALKS
VRTX
SRPT
CRIS
NTLA
EDIT
INCY
ACAD
ALNY
CYTK
IONS
EXAS
IDXX
VNDA
SUPN
RGNX
XOM
CVAC
BNTX
ARCT
MRNA
NBIX
ADPT
AVXL
IMUX
PRGS
RDNT
CRDF
ADSK
ANAB
ATRC
CLDX
CPRX
ESPR
EXEL
FGEN
GALT
GRFS
HRMY
IGC
INSM
KODK
LAKE
LCTX
LEXX
LPCN
MESO
MITK
MNKD
MSFT
MYGN
NEO
NVCR
NXPI
OCGN
OMER
ORCL
PACB
PFE
PLRX
PRGO
PSNL
PTGX
QGEN
RARE
ROST
RVMD
SEIC
SIGA
SMCI
SNOW
SOFI
SPRO
TGTX
TNDM
TXG
ULTA
VEEV
VKTX
VRNS
WVE
XRAY
ZBRA
ZNTL
Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders?
prnewswire.com
SUPN
BOW
ATKR
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN
businesswire.com
SUPN
INDV
Form 8-K
sec.gov
SUPN